Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS2 | P35228 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13137791 | 0.77 | — | — | |
| SCHEMBL9078520 | 0.77 | — | — | |
| SCHEMBL3914525 | 0.77 | — | — | |
| Hydrochloric Acid SCHEMBL11248175 | 0.75 | — | — | |
| SCHEMBL3637086 | 0.71 | — | — | |
| SCHEMBL29023661 | 0.71 | — | — | |
| SCHEMBL12219622 | 0.71 | — | — | |
| SCHEMBL12947548 | 0.71 | — | — | |
| SCHEMBL3637717 | 0.68 | — | — | |
| SCHEMBL14573016 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3328427-B1 | ANTIBODY DERIVATIVES WITH CONDITIONALLY ENABLED EFFECTOR FUNCTION | MASSACHUSETTS GEN HOSPITAL (US) | 2024-05-29 | — | — | EP | disclosed |
| EP-3337917-B1 | SELF-HEALING COATINGS FOR OIL AND GAS APPLICATIONS | BAKER HUGHES HOLDINGS LLC (US) | 2023-10-11 | — | — | EP | disclosed |
| US-20230303709-A1 | Antibody Derivatives with Conditionally Enabled Effector Function | THE GENERAL HOSPITAL CORPORATION | 2023-09-28 | — | — | US | disclosed |
| US-11492503-B2 | Self-healing coatings for oil and gas applications | BAKER HUGHES, A GE COMPANY, LLC (US) | 2022-11-08 | — | — | US | disclosed |
| US-11466093-B2 | Antibody derivatives with conditionally enabled effector function | THE GENERAL HOSPITAL CORPORATION (US) | 2022-10-11 | — | — | US | disclosed |
| US-20180215831-A1 | Antibody Derivatives with Conditionally Enabled Effector Function | THE GENERAL HOSPITAL CORPORATION | 2018-08-02 | — | — | US | disclosed |
| EP-3328427-A1 | ANTIBODY DERIVATIVES WITH CONDITIONALLY ENABLED EFFECTOR FUNCTION | The General Hospital Corporation (US) | 2018-06-06 | — | — | EP | disclosed |
| EP-2046375-B1 | METHODS AND COMPOSITIONS FOR THE SELECTIVE ACTIVATION OF PROTOXINS THROUGH COMBINATORIAL TARGETING | MASSACHUSETTS GEN HOSPITAL (US) | 2017-04-05 | — | — | EP | disclosed |
| WO-2017019729-A1 | ANTIBODY DERIVATIVES WITH CONDITIONALLY ENABLED EFFECTOR FUNCTION | THE GENERAL HOSPITAL CORPORATION (US) | 2017-02-02 | — | — | WO | disclosed |
| EP-2178559-B1 | RECOMBINANT VIBRIO CHOLERAE EXOTOXINS | GEN HOSPITAL CORP (US) | 2015-06-24 | — | — | EP | disclosed |
| US-8993295-B2 | Methods, compositions, and kits for the selective activation of protoxins through combinatorial targeting | THE GENERAL HOSPITAL CORPORATION (US) | 2015-03-31 | — | — | US | disclosed |
| WO-2014031530-A1 | INHIBITING CORROSION CAUSED BY AQUEOUS ALDEHYDE SOLUTIONS | BAKER HUGHES INCORPORATED (US) | 2014-02-27 | — | — | WO | disclosed |
| US-8524241-B2 | Fusion proteins comprising a fragment of Vibrio cholerae exotoxin A | THE GENERAL HOSPITAL CORPORATION (US) | 2013-09-03 | — | — | US | disclosed |
| US-8420094-B2 | — | — | 2013-04-16 | — | — | US | disclosed |
| US-20100256070-A1 | RECOMBINANT VIBRIO CHOLERAE EXOTOXINS | THE GENERAL HOSPITAL CORPORATION | 2010-10-07 | — | — | US | disclosed |
| EP-2178559-A2 | RECOMBINANT VIBRIO CHOLERAE EXOTOXINS | The General Hospital Corporation (US) | 2010-04-28 | — | — | EP | disclosed |
| US-20100055761-A1 | METHODS, COMPOSITIONS, AND KITS FOR THE SELECTIVE ACTIVATION OF PROTOXINS THROUGH COMBINATORAL TARGETING | THE GENERAL HOSPITAL CORPORATION (US) | 2010-03-04 | — | — | US | disclosed |
| EP-2046375-A2 | METHODS, COMPOSITIONS, AND KITS FOR THE SELECTIVE ACTIVATION OF PROTOXINS THROUGH COMBINATORIAL TARGETING | The General Hospital Corporation (US) | 2009-04-15 | — | — | EP | disclosed |
| WO-2009014650-A2 | RECOMBINANT VIBRIO CHOLERAE EXOTOXINS | THE GENERAL HOSPITAL CORPORATION (US) | 2009-01-29 | — | — | WO | disclosed |
| WO-2008011157-A2 | METHODS, COMPOSITIONS, AND KITS FOR THE SELECTIVE ACTIVATION OF PROTOXINS THROUGH COMBINATORIAL TARGETING | THE GENERAL HOSPITAL CORPORATION (US) | 2008-01-24 | — | — | WO | disclosed |